2017
DOI: 10.1016/j.nano.2016.09.016
|View full text |Cite
|
Sign up to set email alerts
|

pH and redox dual-responsive biodegradable polymeric micelles with high drug loading for effective anticancer drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 69 publications
(26 citation statements)
references
References 45 publications
0
26
0
Order By: Relevance
“…DOX showed relatively low absorption (45%) as compared to DNR (77.5%). However, DOX presented high loading efficiency and loading capacity of 55% (550 mg g -1 ) and 27.5% (275 mg g -1 ) relative to DNR, 22.5% (225 mg g -1 ) and 11.25% (112.5 mg g -1 ) (Teo et al 2017). The DOX-and DNR-loaded Ag-NPs showed efficient and remarkable loading efficiency (55, 22.5)% and capacity (27.5, 11.25)%, respectively…”
Section: Anthelmintic Activitymentioning
confidence: 96%
“…DOX showed relatively low absorption (45%) as compared to DNR (77.5%). However, DOX presented high loading efficiency and loading capacity of 55% (550 mg g -1 ) and 27.5% (275 mg g -1 ) relative to DNR, 22.5% (225 mg g -1 ) and 11.25% (112.5 mg g -1 ) (Teo et al 2017). The DOX-and DNR-loaded Ag-NPs showed efficient and remarkable loading efficiency (55, 22.5)% and capacity (27.5, 11.25)%, respectively…”
Section: Anthelmintic Activitymentioning
confidence: 96%
“…Redox responsive PTs include dual-responsive Dox loaded micelles of PEG-polycarbonate diblock copolymers functionalized with disulfide bonds and pH-responsive carboxylic acid groups [ 159 ], PEG-modified redox-responsive chain-shattering polymeric therapeutic (CSPT) drug carriers [ 160 ] and additional PUMPT strategies [ 161 ].…”
Section: Hurdle 3: Intracellular Release Of Active Agentmentioning
confidence: 99%
“…The success of these drugs depends on the fabrication of bioavailability carriers with high drug loading capabilities and no early release [165]. The drug delivery agent should have a compatibility with the drug [166], be capable of encapsulation [167], feature high drug loading [168], and have the appropriate release rate [169]. Due to their importance, changeless drug delivery systems are focused structurally so that drug materials are transmitted without immediate release to the target site [165].…”
Section: Application Of Silica Mesopores In Drug Deliverymentioning
confidence: 99%